KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Non-Current Assets (2019 - 2025)

Clover Health Investments' Non-Current Assets history spans 7 years, with the latest figure at $233.2 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 1.88% year-over-year to $233.2 million; the TTM value through Dec 2025 reached $926.3 million, up 1360.96%, while the annual FY2025 figure was $233.2 million, 1.88% down from the prior year.
  • Non-Current Assets reached $233.2 million in Q4 2025 per CLOV's latest filing, up from $228.7 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $498.2 million in Q2 2021 to a low of -$536.8 million in Q1 2023.
  • Average Non-Current Assets over 5 years is $65.2 million, with a median of $165.6 million recorded in 2022.
  • Peak YoY movement for Non-Current Assets: plummeted 384.8% in 2023, then skyrocketed 15390.04% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $198.3 million in 2021, then plummeted by 236.31% to -$270.2 million in 2022, then surged by 152.8% to $142.7 million in 2023, then soared by 66.51% to $237.6 million in 2024, then dropped by 1.88% to $233.2 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Non-Current Assets are $233.2 million (Q4 2025), $228.7 million (Q3 2025), and $212.0 million (Q2 2025).